InsideTrading SEC Form 4 insider trades

Stocks

MNPR Monopar Therapeutics

Healthcare · Pharmaceutical Preparations · Market cap: $483.3M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $49.7K, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $99.9K, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $25.2K, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $1.2M 2025-Q3: bought $0, sold $36.7M 2025-Q4: bought $104.9K, sold $343.9K 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $3.4M 2026-Q4: bought $0, sold $1.2M
Bought, above the line (largest quarter $104.9K) Sold, below the line (largest quarter $36.7M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$49.7K$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$99.9K$0
2024-Q3$0$0
2024-Q4$25.2K$0
2025-Q1$0$0
2025-Q2$0$1.2M
2025-Q3$0$36.7M
2025-Q4$104.9K$343.9K
2026-Q1$0$0
2026-Q2$0$0
2026-Q3$0$3.4M
2026-Q4$0$1.2M

Insider activity

Download CSV Up to 5,000 rows
Bought$279.7K14 buy days
Sold$42.8M14 sell days
Net insider flow-$42.5Mnet selling · 5 years
Latest trade2026-11-04Tsuchimoto Kim R
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-11-04 Sell Tsuchimoto Kim R Director 2,891 $71.26 $206.0K 3
2026-11-02 Sell Anderson Raymond Director 3,142 $68.35 $214.7K 4
2026-11-02 Sell Tsuchimoto Kim R Director 1,199 $70.10 $84.0K 1
2026-10-01 Sell STARR CHRISTOPHER M Director 8,400 $78.50 $659.4K 3
2026-09-24 Sell Robinson Chandler CEO 29,056 $88.00 $2.6M 4
2026-08-26 Sell Tsuchimoto Kim R Director 4,090 $111.39 $455.6K 6
2026-08-26 Sell RIOUX PATRICE Other 1 $111.26 $111 1
2026-08-25 Sell Anderson Raymond Director 3,788 $111.65 $422.9K 4
2025-12-26 Buy Vu Quan Anh CFO 1,500 $69.95 $104.9K 1
2025-12-18 Sell KLAUSNER ARTHUR J Director 5,121 $67.15 $343.9K 2
2025-09-24 Sell Tactic Pharma LLC CEO 550,229 $63.61 $35.0M 1
2025-07-14 Sell STARR CHRISTOPHER M Director 16,800 $40.00 $672.0K 1
2025-07-14 Sell Robinson Chandler CEO 16,800 $40.00 $672.0K 1
2025-07-14 Sell Tsuchimoto Kim R Director 8,904 $40.00 $356.2K 1
2025-04-02 Sell Tactic Pharma LLC CEO 33,334 $35.00 $1.2M 1
2024-10-28 Buy Radhakrishnan Karthik CFO 1,550 $16.25 $25.2K 1
2024-06-20 Buy Cittadine Andrew COO 20,508 $0.74 $15.2K 1
2024-06-18 Buy Cittadine Andrew COO 12,000 $0.86 $10.3K 1
2024-06-17 Buy Cittadine Andrew COO 12,000 $0.90 $10.8K 1
2024-06-14 Buy Cittadine Andrew COO 12,000 $0.93 $11.2K 1
2024-06-13 Buy Cittadine Andrew COO 12,000 $0.91 $10.9K 1
2024-06-04 Buy Cittadine Andrew COO 12,000 $0.78 $9.4K 1
2024-06-03 Buy Cittadine Andrew COO 12,000 $0.76 $9.1K 1
2024-05-31 Buy Cittadine Andrew COO 12,000 $0.64 $7.7K 1
2024-05-30 Buy Cittadine Andrew COO 12,000 $0.64 $7.7K 1
2024-05-29 Buy Cittadine Andrew COO 12,000 $0.64 $7.7K 1
2022-11-15 Buy Cittadine Andrew COO 10,000 $3.15 $31.5K 1
2022-11-14 Buy Cittadine Andrew COO 6,053 $3.00 $18.2K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Robinson Chandler CEO $0 $39.4M 2026-09-24
STARR CHRISTOPHER M Director $0 $1.3M 2026-10-01
Tsuchimoto Kim R Director $0 $1.1M 2026-11-04
Anderson Raymond Director $0 $637.7K 2026-11-02
KLAUSNER ARTHUR J Director $0 $343.9K 2025-12-18
Cittadine Andrew COO $149.6K $0 2024-06-20
Vu Quan Anh CFO $104.9K $0 2025-12-26
Radhakrishnan Karthik CFO $25.2K $0 2024-10-28
RIOUX PATRICE Other $0 $111 2026-08-26

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2019-12-18 4 $6.0M 54 -38.5% (-36.3% raw)-48.6% (-71.4% raw)-65.0% (-69.5% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.